. 2023 Dec 19;46(1):751–768. doi: 10.1007/s11357-023-01041-8

Table 1.

Demographic and clinical variables, mean (standard deviation)

	AD (N = 36)	CN (N = 29)	FTD (N = 23)	Group differences
Male to female	12:24	18:11	14:9	χ² = 6.8, p = 0.034^a p (AD, CN) = 0.021 p (AD, FTD) = 0.038 p (CN, FTD) = 0.930
Age	66.4(7.9)	67.9(5.4)	63.7(8.2)	F (2, 85) = 2.218, p = 0.115^b
MMSE	17.8(4.5)	30(0)	22.2(2.6)	t₅₇ = − 4.3, p < 0.001^c

AD (N = 36)

CN (N = 29)

FTD (N = 23)

Group differences

Male to female

12:24

18:11

14:9

χ² = 6.8, p = 0.034^a

p (AD, CN) = 0.021

p (AD, FTD) = 0.038

p (CN, FTD) = 0.930

Age

66.4(7.9)

67.9(5.4)

63.7(8.2)

F (2, 85) = 2.218, p = 0.115^b

MMSE

17.8(4.5)

30(0)

22.2(2.6)

t₅₇ = − 4.3, p < 0.001^c

AD Alzheimer’s disease, CN healthy control, FTD frontotemporal dementia, MMSE Mini-Mental State Examination

^aChi-square test AD, CN, FTD

^bOne-way ANOVA AD, CN, FTD

^cStudent’s t-test AD, FTD